Enzyre, which is developing breakthrough ambulant diagnostic technology for coagulation testing, announces today the appointment of Dirk Pollet as Chief Executive Officer. It also announces the award of €2M European Fund for Regional Development (EFRO) grant and closing of a successful seed funding round which enables Enzyre to accelerate the development of its unique Hemophilia Biochip technology. Enzyres platform technology requires jus....
Tags : Enzyre, ambulant diagnostic technology, coagulation testing, European Fund for Regional Development, Hemophilia Biochip technology, Radboud University Medical Center,
comments (0)